missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Mirikizumab Recombinant Human Monoclonal Antibody, Invitrogen™
Human Recombinant Monoclonal Antibody
Brand: Invitrogen MA542172
This item is not returnable.
View return policy
Description
Endotoxin level < 0.01EU/μg by LAL method Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 °C for one week. Store at -20 to -80 °C for twelve months from the date of receipt.
Mirikizumab is a humanized IgG4 monoclonal antibody that targets p19 subunit of IL-23. Currently, mirikizumab is being developed for a variety of immune diseases, including psoriasis, UC, and Crohn's disease (CD). Among them, the treatment of moderate to severe plaque psoriasis is in phase III clinical trials.Specifications
Mirikizumab | |
Recombinant Monoclonal | |
Unconjugated | |
LY-3074828 | |
Human IL23A | |
100 μg | |
Primary | |
-20° C, Avoid Freeze/Thaw Cycles | |
Liquid | |
Chemical |
ELISA, SDS-Page | |
1.76 mg/mL | |
PBS with no preservative; pH 7.5 | |
Human | |
Protein A | |
RUO | |
Chemical | |
Antibody | |
IgG4 κ |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction